Globus Medical to buy Nevro in $250M all-cash deal
The deal is expected to close in late Q2 2025, subject to Nevro shareholder and regulatory approval.Globus Medical also ...
Business Insider26d
Nevro is not issuing FY25 guidance
As previously announced on February 6, given the pending acquisition of Nevro (NVRO) by Globus Medical, Nevro is not issuing FY25 guidance, nor is the company holding an earnings conference call ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...
La Grande Observer26d
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
2025 Financial Guidance and Fourth-Quarter 2024 Earnings Conference Call and Webcast As previously announced on February 6, 2025, given the pending acquisition of Nevro by Globus Medical ...
Globus Medical, Inc. (NYSE:GMED) Shares Bought by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. lifted its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 3.0% ...